Welcome to our dedicated page for Atlanta Braves Holdings SEC filings (Ticker: BATRK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Atlanta Braves Holdings, Inc. (Nasdaq: BATRK) provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Atlanta Braves Holdings is a Nevada corporation whose business consists primarily of the Atlanta Braves Major League Baseball Club and a mixed-use real estate portfolio that includes The Battery Atlanta and related properties such as Pennant Park.
Through this page, users can review current and historical filings, including Form 8-K reports that describe material events. Recent 8-K filings for BATRK have covered topics such as quarterly financial results and performance stock unit awards granted under the company’s omnibus incentive plan. These documents offer detail on segment performance for Baseball and Mixed-Use Development, the company’s definition and use of Adjusted OIBDA, and certain compensation arrangements for named executive officers.
Investors can also use this section to locate periodic reports such as Forms 10-K and 10-Q when filed, which typically contain segment disclosures, risk factor discussions, capital structure information and reconciliations of non-GAAP measures to GAAP results. In addition, the filings page is a resource for tracking governance-related disclosures, equity incentive plans and other items that may appear in registration statements or proxy materials.
Stock Titan enhances these filings with AI-powered summaries that highlight key points, explain complex sections in simpler terms and help users quickly identify information related to revenue sources, segment results, non-GAAP metrics and executive compensation. Real-time updates from EDGAR ensure that new BATRK filings, including any future Forms 4 for insider transactions, are made available promptly for review and analysis.
Atlanta Braves Holdings, Inc. executive Jill L. Robinson, EVP, CFO & Treasurer, exercised options for 60,000 shares of Series C Common Stock at a stated exercise price of
After these transactions, she directly owned 79,460 Series C Common shares and 30,263 stock options. The sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on
A holder of Series C Common Stock filed a notice of intent to sell 60,000 shares through UBS Financial Services on the NASDAQ, with an aggregate market value of
The 60,000 shares to be sold were acquired on 02/13/2026 via an exercise of stock options, with payment made the same day. The filing also lists recent sales over the past three months by Jill Robinson, including 6,875 shares on 12/05/2025 for
Atlanta Braves Holdings investor John C. Malone filed an amended Schedule 13D showing he now beneficially holds a majority of the company’s voting power. He owns 557,039 shares of Series A common stock (about 5.4% of that class) and 949,201 shares of Series B common stock (about 97.1% of that class), giving him approximately 50.01% of the voting power in director elections.
Recent purchases include 4,631 and 2,259 Series A shares in November 2025 at prices around $42, 3,669 Series B shares on February 4, 2026 at $48.17, and 35,000 Series A shares on February 5, 2026 at a volume-weighted average price of $44.23. Because he now holds a voting majority, the company will be deemed a “Controlled Company” under Nasdaq rules, and Malone can exert significant influence over the board, major transactions, and other matters requiring shareholder approval.
Atlanta Braves Holdings, Inc. investor John C. Malone has updated his ownership, reporting beneficial control of about 50.01% of the company’s voting power in director elections through Series A and high‑vote Series B common stock.
He directly and indirectly holds 557,039 shares of Series A Common Stock, or about 5.4% of that class, and 949,201 shares of Series B Common Stock, or about 97.1% of that class, based on the share counts outstanding as of October 31, 2025. Recent purchases include multiple open‑market buys of Series A between $41.96 and $44.74 per share and a privately negotiated Series B purchase at $48.17 per share.
Because Malone now beneficially holds more than a majority of the outstanding voting securities, Atlanta Braves Holdings will be deemed a “Controlled Company” under Nasdaq rules, giving him significant influence over the board, major transactions and other matters requiring shareholder approval, subject to Major League Baseball rules and existing voting agreements.
Atlanta Braves Holdings executive Jill L. Robinson exercised stock options and sold shares of Series C Common Stock. On 02/02/2026, she exercised options for 20,000 BATRK shares at an exercise price of $27.18 per share and received 20,000 shares.
That same day, she sold 20,000 Series C Common shares at a weighted average price of $40.00 per share, within a range of $39.71 to $40.22, under a pre-arranged Rule 10b5-1 trading plan adopted on May 15, 2025. After these transactions, she directly owned 79,460 Series C Common shares and held 90,263 stock options.
A shareholder of BATRA, identified as Jill Robinson, has filed a Form 144 indicating an intention to sell 20,000 shares of Series C Common Stock through UBS Financial Services on NASDAQ at an aggregate market value of $800,028.
The shares are scheduled for approximate sale on February 2, 2026 and were acquired the same day via a cash exercise of stock options for 20,000 shares. The issuer had 51,627,382 shares outstanding of the same class at the time referenced. Robinson also sold Series C Common shares in three prior transactions over the past three months, with individual sales of 20,000, 6,875 and 3,830 shares.
The Vanguard Group has filed an amended Schedule 13G reporting beneficial ownership of 733,932 shares of Atlanta Braves Holdings Inc common stock, representing 7.11% of the class as of the event date of 12/31/2025.
Vanguard reports shared voting power over 144,675 shares and shared dispositive power over all 733,932 shares, with no sole voting or dispositive power. The filing states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
The filing also notes that on 01/12/2026 Vanguard underwent an internal realignment, after which certain subsidiaries or business divisions with beneficial ownership will report on a disaggregated basis. Vanguard’s clients, including registered investment companies and other managed accounts, have rights to dividends or sale proceeds, but no single other person has more than a 5% interest in these securities.
The Vanguard Group reported beneficial ownership of 2,789,081 shares of Atlanta Braves Holdings Inc. common stock, representing 5.4% of the class as of the event date 12/31/2025.
Vanguard reports shared voting power over 326,604 shares and shared dispositive power over all 2,789,081 shares, with no sole voting or dispositive power. The shares are held on behalf of Vanguard’s clients, none of whom individually owns more than 5% of the class. Vanguard notes an internal realignment effective 01/12/2026, after which certain subsidiaries are expected to report beneficial ownership separately.
Reporting persons including GAMCO Investors, Associated Capital Group, GGCP Inc., and Mario J. Gabelli disclosed multiple sales of Atlanta Braves Holdings, Inc. Series A common stock in mid-September 2025. Reported transactions include an 800-share sale on 09/18/2025 at $45.4888 and a 1,100-share sale on 09/19/2025 at $45.1945, plus additional dispositions or indirect ownership adjustments totaling at least 98,452 shares across several entries. Post-transaction beneficial ownership amounts shown include 2,900 shares and 1,800 shares for specific entries, with other blocks held indirectly by named investment partnerships and entities. The filings note disgorgement payments to the issuer for the two sales and explain that reported beneficial ownership reflects total holdings of entities exceeding the reporting persons' direct pecuniary interests.
Gregory John Heller, EVP, CLO & Secretary of Atlanta Braves Holdings, Inc. (BATRK), exercised options and sold shares on 08/21/2025. He exercised a stock option with a $27.18 exercise price to acquire 60,000 shares of Series C common stock and immediately sold 60,000 shares at a weighted average sale price of $43.45, with the sale price range reported as $43.09 to $43.70. After these transactions he beneficially owned 14,876 shares of Series C common stock directly and 80,263 shares through previously held derivative securities or other holdings.
The Form 4 was signed by an attorney-in-fact on 08/22/2025 and discloses the option grant’s original grant date (12/10/2023) and option expiration date (12/10/2027). The filing notes the reported sale price is a weighted average and that detailed per-price sale breakdowns are available upon regulatory request.